QuidelOrtho Corporation (LON:0A55)

Market Cap	1.18B -52.1%
Revenue (ttm)	2.02B -1.9%
Net Income	-839.27M
EPS	-12.38
Shares Out	n/a
PE Ratio	n/a
Forward PE	10.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61
Average Volume	177
Open	43.09
Previous Close	43.64
Day's Range	43.09 - 43.50
52-Week Range	29.91 - 69.67
Beta	n/a
RSI	49.59
Earnings Date	Feb 11, 2026

About QuidelOrtho

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease,...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1979
• Employees: 6,600
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A55

Financial Performance

In 2025, QuidelOrtho's revenue was $2.73 billion, a decrease of -1.89% compared to the previous year's $2.78 billion. Losses were -$1.13 billion, -44.84% less than in 2024.

Financial numbers in USD